Understanding FDAs Governance of Prescription Drug Development: Manufacturing/cGMPs, Submission Process and Post Approval Commitments - Part 2
Website https://www.complianceonline.com/fda-prescription-drug-develop-cgmp-part-2-webinar-training-706159-p |
Edit Freely
Category
Deadline: September 25, 2019 | Date: September 25, 2019
Venue/Country: U.S.A
Updated: 2019-08-15 02:00:10 (GMT+9)
Call For Papers - CFP
In this webinar, we will review in detail major considerations to be well-thought-out during the prescription drug product development process. We will review in depth FDA cGMPs and their importance in drug manufacturing. We will review the submission process and post-approval commitments. This webinar is Part 2 of a 2 Part series.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.